SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-023281
Filing Date
2012-04-23
Accepted
2012-04-23 21:54:07
Documents
1
Period of Report
2012-04-12

Document Format Files

Seq Description Document Type Size
1 form323716_20120423095312-.html 3  
1 form323716_20120423095312-.xml 3 5127
  Complete submission text file 0001144204-12-023281.txt   6809
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS ADVISORS LLC (Reporting) CIK: 0001263508 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-23155 | Film No.: 12774437